Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Improvements of Procedural Results With a New‐Generation Self‐Expanding Transfemoral Aortic Valve Prosthesis in Comparison to the Old‐Generation Device

Improvements of Procedural Results With a New‐Generation Self‐Expanding Transfemoral Aortic Valve... © 2016, Wiley Periodicals, Inc. DOI: 10.1111/joic.12356 STRUCTURAL HEART DISEASE Improvements of Procedural Results With a New-Generation Self-Expanding Transfemoral Aortic Valve Prosthesis in Comparison to the Old-Generation Device BRUNA GOMES, M.D., NICOLAS A. GEIS, M.D., EMMANUEL CHORIANOPOULOS, M.D., BENJAMIN MEDER, M.D., FLORIAN LEUSCHNER, M.D., HUGO A. KATUS, M.D., and RAFFI BEKEREDJIAN, M.D. From the Department of Internal Medicine III, University of Heidelberg, Heidelberg, Germany Objectives: In this study, we compare procedural results of our first Evolut R (Medtronic, Minneapolis, MN, USA) implantations with the last CoreValve implantations. Main endpoints include paravalvular regurgitation, major vascular complications, stroke, and pacemaker implantation. Background: The evolution of transcatheter aortic valve replacement (TAVR) was possible due to various technical improvements, leading to better periprocedural and long-term outcome. The newly designed Evolut R valve has the potential to further improve TAVR’s performance. Methods: We retrospectively analyzed our first 100 consecutive patients who received the Evolut R valve with the last 100 consecutive patients who received the CoreValve prosthesis between July 2013 and February 2016. Only patients treated with a 26 mm or 29 mm bioprosthesis were included. Results: No significant differences in patient characteristics were noticed. Both angiography and echocardiography after TAVR showed significantly higher http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Interventional Cardiology Wiley

Improvements of Procedural Results With a New‐Generation Self‐Expanding Transfemoral Aortic Valve Prosthesis in Comparison to the Old‐Generation Device

Download PDF
7 pages

Loading next page...
 
/lp/wiley/improvements-of-procedural-results-with-a-new-generation-self-72f0y64zgL

References (21)

Publisher
Wiley
Copyright
© 2017 Wiley Periodicals, Inc.
ISSN
0896-4327
eISSN
1540-8183
DOI
10.1111/joic.12356
pmid
27882613
Publisher site
See Article on Publisher Site

Abstract

© 2016, Wiley Periodicals, Inc. DOI: 10.1111/joic.12356 STRUCTURAL HEART DISEASE Improvements of Procedural Results With a New-Generation Self-Expanding Transfemoral Aortic Valve Prosthesis in Comparison to the Old-Generation Device BRUNA GOMES, M.D., NICOLAS A. GEIS, M.D., EMMANUEL CHORIANOPOULOS, M.D., BENJAMIN MEDER, M.D., FLORIAN LEUSCHNER, M.D., HUGO A. KATUS, M.D., and RAFFI BEKEREDJIAN, M.D. From the Department of Internal Medicine III, University of Heidelberg, Heidelberg, Germany Objectives: In this study, we compare procedural results of our first Evolut R (Medtronic, Minneapolis, MN, USA) implantations with the last CoreValve implantations. Main endpoints include paravalvular regurgitation, major vascular complications, stroke, and pacemaker implantation. Background: The evolution of transcatheter aortic valve replacement (TAVR) was possible due to various technical improvements, leading to better periprocedural and long-term outcome. The newly designed Evolut R valve has the potential to further improve TAVR’s performance. Methods: We retrospectively analyzed our first 100 consecutive patients who received the Evolut R valve with the last 100 consecutive patients who received the CoreValve prosthesis between July 2013 and February 2016. Only patients treated with a 26 mm or 29 mm bioprosthesis were included. Results: No significant differences in patient characteristics were noticed. Both angiography and echocardiography after TAVR showed significantly higher

Journal

Journal of Interventional Cardiology – Wiley

Published: Feb 1, 2017

There are no references for this article.